Presented for research literature review only de Meester C (1984)
Driven by high-profile trial data, the FDA is evaluating expanded indications, higher-dose formats, and oral daily pills
Statements Author contributions QH: Supervision, Conceptualization, Writing original draft, Funding acquisition
Wegovy may be recommended for adult patients who are: Medically overweight or obese (BMI of 30 or higher), or Have a BMI of 27 or higher and at least one weight-related health condition, such as type 2 diabetes, high blood pressure, or high cholesterol
After we think in most of the mouse liver resection, the stress as a result of the surgery, peripheral fat mobilization and serum ALT, AST causes residual liver cells increased burden, gathered a large number of lipid in liver cell formation of lipid droplets, the lipid on the one hand, can give a short period through the beta oxidation liver regeneration process that require large amounts of energy to provide energy, In contrast, excessive accumulation of lipid droplets will cause aseptic inflammation to hepatocytes and damage liver function, which is a double-edged sword